Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > Any-news about the meeting?

<< Previous

Bullboard Posts

Next >>

Comment by qwerty22on Oct 29, 2020 1:31pm

92 Views

Post# 31804302

RE:RE:RE:RE:RE:RE:Any-news about the meeting?

There was one statement early on that sounded like they'd finished the IND but as you said later he did suggest it's still on going.

SPCEO1 wrote: Also, they said again that they plan to put their protocol forward in Q4. Sounds like more delays to me as I had second hand accounts about a week or so ago that they might be within 10 days of submitting it. That may still be true but the way Paul stated it made it seem like those expectations for a quick filing of the protocol might be too aggressive. Just guessing on my part.

SPCEO1 wrote: I will defer to Qwerty, JFM and others with a deep medical understanding to amke comments about it. IT is not over yet but I thought Paul and Christian made the points they wanted to make. But they made too many points about Lipo, Trogarzo and cancer and that was wasting the time of the listeners as this is a NASH program. But I understand they are trying to introduce the whole company to the listeners - I just don't think it was needed or certainly could have been shortened considerably.

Adonis wrote: Any-news ??